The quarterly results of Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) were released last week, making it a good time to review its performance. Revenue was 499% higher than analysts’ model forecast, at US $ 11 million, although statutory losses swelled 217% to US $ 1.45, which is much worse than expected. Profits are an important time for investors because they can follow a company’s performance, look at what analysts are forecasting for next year, and see if there has been a change in sentiment towards the company. Readers will be happy to know that we have aggregated the latest statutory forecast to see if analysts have changed their minds on Mirum Pharmaceuticals after the latest results.

Check out our latest review for Mirum Pharmaceuticals

NasdaqGM: MIRM Profits and Revenue Growth August 9, 2021

Based on the latest results, the most recent consensus for Mirum Pharmaceuticals of seven analysts is for 2021 revenue of US $ 37.0 million, which, if achieved, would represent a significant increase of 237 million. % of its sales in the last 12 months. Losses are expected to decline 2.2% to US $ 5.37 per share. Prior to this latest report, the consensus was expecting revenues of US $ 38.8 million and US $ 3.83 per share of losses. So it’s pretty clear that analysts have mixed opinions on Mirum Pharmaceuticals after this update; earnings have been lowered and losses per share are expected to increase.

The average price target was broadly unchanged at US $ 49.43, perhaps implicitly signaling that the weaker earnings outlook should not have a long-term impact on valuation. This is not the only conclusion we can draw from this data, however, as some investors also like to factor in the spread in estimates when evaluating analysts’ price targets. Currently, the most bullish analyst values Mirum Pharmaceuticals at US $ 77.00 per share, while the most bearish price at US $ 30.00. Notice the wide gap in analysts’ price targets? This implies for us that there is a fairly wide range of possible scenarios for the underlying activity.

The bottom line

The most important thing to remember is that analysts have increased their estimates of loss per share for the next year. They also lowered their revenue estimates, although industry data suggests Mirum Pharmaceuticals revenue is expected to grow faster than the industry as a whole. There has been no real change to the consensus price target, suggesting that the intrinsic value of the company has not undergone any major changes with the latest estimates.

Continuing this reflection, we believe that the long-term prospects of the company are much more relevant than the results of next year. We have estimates – from several analysts at Mirum Pharmaceuticals – up to 2023, and you can see them for free on our platform here.

In addition, you should also educate yourself about the 3 warning signs we spotted with Mirum Pharmaceuticals.

Promoted
If you decide to trade Mirum Pharmaceuticals, use the cheapest platform * which is ranked # 1 overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, currencies, bonds and funds in 135 markets, all from one integrated account.

This Simply Wall St article is general in nature. It does not constitute a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Our aim is to bring you long-term, targeted analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price sensitive companies or qualitative material. Simply Wall St has no position in the mentioned stocks.
^*Interactive Brokers Ranked Least Expensive Broker By StockBrokers.com Online Annual Review 2020

Do you have any feedback on this item? Are you worried about the content? Enter into a contract with us directly. You can also send an email to the editorial team (at) simplywallst.com.

August 8, 2021

Financial statement fraud market to see booming business sentiments

The global financial statement fraud market size is expected to increase with a CAGR of xx% during the forecast period 2021 to 2027 and is expected to reach US $ xx million by 2027, from US $ xx million in 2020.

Global “Financial statement fraud market The 2020-2026 research report is a historical overview and in-depth study of the current and future market of the Financial Statement Fraud industry. The report represents a basic overview of Financial Statements Fraud market share, competitor segment with a basic introduction of major vendors, major regions, product types and end industries. This report provides a historical overview of financial fraud market trends, growth, revenue, capacity, cost structure, and key driver analysis.

The comprehensive study of the Financial Statements Fraud Market 2021 report brings to you an analysis of the market size, share, growth, expansion of the market, technological innovations, trends, cost structure, revenue, statistical and comprehensive data of the global market. The major players covered in this report are: Enron Corporation, FICO, Moss Adams, SAS Institute, IBM, BAE Systems, LexisNexis, Core, PwC Australia, DXC Technology

Get Sample PDF Report @ https://www.marketintellix.com/sample-request/global-financial-statement-fraud-market-86385

Highlights of the Covid-19 impact assessment:

Economic impact of the covid-19 pandemic around the world.
Changes in demand and in the supply chain of the business division.
Long and short term effects of the pandemic on industry revenues.

The best companies listed here:

Enron Corporation
FICO
Adams foam
SAS Institute
IBM
BAE systems
LexisNexis
Heart
PwC Australia
DXC technology

Regions Covered By The Financial Statement Fraud Market Report:

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, etc.)
Middle East and Africa (Egypt and GCC countries)

Educate yourself and share your questions, if any, prior to purchase on this report at: https://www.marketintellix.com/enquiry-before-buy/global-financial-statement-fraud-market- 86385

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, mainly divided into:

Financial statement fraud detection solutions
Financial statement fraud prevention solutions

On the basis of end users / applications, this report focuses on the status and outlook for major applications / end users, consumption (sales), market share and growth rate of each application, including:

Large companies
Small and medium-sized enterprises (SMEs)

Some of the key questions this report answered:

What will the market growth rate, growth dynamics or market acceleration be during the forecast period?
What are the key factors driving the Financial Statement Fraud market?
What was the size of the emerging financial statement fraud market by value in 2019?
• What will be the size of the emerging financial statement fraud market in 2026?
Which region is expected to hold the highest market share in the Financial Statement Fraud Market?
What trends, challenges, and obstacles will impact the development and size of the global financial statement fraud market?
What are the sales volume, revenue, and price analysis of the major manufacturers of the Financial Statement Fraud market?
What are the Financial Statement Fraud Market opportunities and threats faced by the vendors in the global Financial Statement Fraud Market?

With tables and figures helping to analyze the global Financial Statement Fraud Market, this research provides key statistics on the state of the industry and is a valuable source of advice and direction for businesses and organizations alike. individuals interested in the market.

Years considered for this report:

Historical years: 2015-2019

Baseline year: 2019

Estimated year: 2020

Financial Statement Fraud Market Forecast Period: 2020-2026

Contents

Overview of the Financial Statement Fraud Market
Financial Statement Fraud Market Landscape by Player
Player Profiles
Financial statement fraud production, revenue (value), price trend by type
Financial Statement Fraud Market Analysis by Application
Financial Statements Fraud Production, consumption, export, import by region (2015-2019)
Financial Statement Fraud Production, Revenue (Value) by Region (2015-2019)
Financial statement fraud fabrication analysis
Industrial chain, sourcing strategy and downstream buyers
Market dynamics
Financial Statement Fraud Market Forecast (2020-2026)
Research findings and conclusion
Annex

Request a discount on the standard prices of this premium search @ https://www.marketintellix.com/discount-request/global-financial-statement-fraud-market-86385

You can also get report versions by chapter or region like North America, Europe or Asia or countries like US, UK, China and others.

About Market Intellix

Market Intellix is an expert in the field of global market research consulting. Using our ingenious, expert-built database, we offer our clients a wide range of bespoke marketing and business research solutions to choose from. We help our clients better understand the strengths and weaknesses of different markets, as well as how to capitalize on opportunities. Covering a wide variety of market applications, we are your one stop solution for everything from data collection to investment advice, covering a wide variety of market areas, from digital products to the food industry.

Our knowledgeable research team will work with you to learn more about the preferences, behaviors, attitudes, and other details of your current and future customers. Our team of market research experts will provide you with the most comprehensive and reliable data to help you assess and make the best possible strategic marketing decisions.

Contact us

Intellix Market LLP

Steven jones

Media and Marketing Manager

Address: SN 87/2, Kashid Park, Near Tresor Park, Pune, Maharashtra – 411207, India

Call: +1 (350) 908 1001

Email: [email protected]

Website: www.marketintellix.com

August 6, 2021

Silvano Fashion Group Consolidated Interim Financial Report

Selected financial indicators

The summary of the Group’s selected financial indicators for 6 months 2021 compared to 6 months 2020 and 06/30/2021 compared to 12/31/2020 is as follows:

in thousands of euros	06min 2021	06min 2020	Change
Income	23 225	17,731	31.0%
Gross profit	13 661	10,575	29.2%
Operating result	7 941	3 983	99.4%
EBITDA	9,533	5,931	60.7%
Net income for the period	6,696	870	669.7%
Net income share of shareholders of the Parent Company	6,031	745	709.5%
Earnings per share (EUR)	0.17	0.02	750.0%
Operating cash flow for the period	8 055	2,742	193.8%

in thousands of euros	06/30/2021	31.12.2020	Change
Total assets	49,446	42,256	17.0%
Total current assets	36,381	29,597	22.9%
Total equity attributable to shareholders of the Parent Company	30,497	24,504	24.5%
Cash and cash equivalents	14,022	8 980	56.1%

Margin analysis,%	06min 2021	06min 2020	Change
Gross profit	58.8	59.6	-1.3%
Operating result	34.2	22.5	52.0%
EBITDA	41.0	33.4	22.8%
Net profit	28.8	4.9	487.8%
Net income attributable to shareholders of the Parent Company	26.0	4.2	519.0%

Financial ratios,%	06/30/2021	31.12.2020	Change
ROA	23.7	3.2	640.6%
DEER	40.2	5.6	617.9%
Price / earnings ratio (P / E)	5.5	41.7	-86.8%
Current ratio	4.0	3.4	17.6%
Quick report	1.8	1.3	38.5%

Financial performance

Group sales amounted to 23,225 thousand euros over the 6 months of 2021, an increase of 31.0% compared to the same period of the previous year. Overall, wholesale trade increased by 40.1%, measured in EUR.

The gross margin of the Group over the 6 months of 2021 amounted to 13,661 thousand euros and increased by 29.2% compared to the previous year. The gross margin in the 6 months of 2021 decreased to 58.8%, compared to 59.6% in the respective period of the previous year. The cost of goods sold increased 33.7%.

Consolidated operating income for the six months of 2021 amounted to € 7,941 thousand, compared to € 3,983 thousand for the six months of 2020, up 99.4%. The consolidated operating margin stands at 34.2% over 6 months 2021 (22.5% over 6 months 2020). Consolidated EBITDA for the 6 months of 2021 increased by 60.7% and amounts to 9,533 thousand euros, or 41.0% in terms of margin (5,931 thousand euros and 33.4% for the 6 months of 2020).

The consolidated net profit attributable to the shareholders of the parent company published for the 6 months of 2021 amounts to 6,031 thousand euros, against a net profit of 745 thousand euros during the 6 months of 2020, the profit margin Net attributable to shareholders of the parent company for 6 months of 2021 was 26.0% compared to 4.2% in 6 months of 2020.

Financial situation

As of June 30, 2021, consolidated assets amounted to 49,446 thousand euros, an increase of 17.0% compared to the situation as of December 31, 2020.

Trade and other receivables increased by 273 thousand euros compared to December 31, 2020 and amount to 2,361 thousand euros as of June 30, 2021. The balance of inventories increased by 1,469 thousand euros and amounted to € 19,996 thousand as of June 30, 2021.

Equity attributable to shareholders of the parent company increased by € 5,993 thousand and amounted to € 30,497 thousand at June 30, 2021. Current liabilities increased by € 255 thousand over the 6 month 2021.

Investments

During the 6 months of 2021, the Group’s investments in tangible fixed assets amounted to 120,000 EUR, compared to 133,000 EUR for the same period of the previous year. Investments were made mainly in the opening and renovation of clean stores, as well as in equipment and facilities to maintain efficient production for future periods.

Staff

As of June 30, 2021, the Group employed 1,696 people, including 518 people in retail. The rest were employed in production, wholesale, administration and support operations. As of 12.31.2020, there were 1,744 employees, including 500 people in retail operations.

The total of salaries and related taxes during the 6 months of 2021 amounted to 4,745 thousand euros (5,008 thousand euros during the 6 months of 2020). The remuneration of the main executives of the Group, including the principal executives of all the subsidiaries, amounts to 293 thousand euros.

Consolidated statement of financial position

in thousands of euros	To note	06/30/2021	31.12.2020
		Unaudited	Checked
ASSETS
Current assets
Cash and cash equivalents	2	14,022	8 980
Outstanding loans granted		2	2
Customers and other debtors	3	2,361	2,088
Inventories	4	19,996	18,527
Total current assets		36,381	29,597

Non-current assets
Long-term receivables		268	249
Investments in associated companies		59	57
Investments in other actions		250	238
Deferred tax asset		1,091	1,032
Intangible assets		462	374
Investment property		1,053	1,018
Tangible fixed assets	5	9 882	9,691
Total non-current assets		13,065	12 659
TOTAL ASSETS		49,446	42,256

LIABILITIES AND EQUITY
Current liabilities
Short-term loans		0	400
Short-term rental debts		1,283	2 121
Suppliers and other creditors	6	5 815	5,583
Government grants		56	0
Tax debts		1,880	675
Total current liabilities		9,034	8,779

Non-current liabilities
Deferred tax liability		584	500
Long term loans		0	400
Long-term rental obligations		5,707	4,707
Long-term arrangements		55	52
Total non-current liabilities		6,346	5 659
Total responsibilities		15,380	14,438

Equity
Share the capital	7	3,600	3,600
Sharing bonus		4 967	4 967
Statutory reserve capital		1,306	1,306
Revaluation reserve		0	355
Unrealized exchange differences		-18,547	-18,864
Retained earnings		39,171	33 140
Total equity attributable to shareholders of the Parent Company		30,497	24,504
Non-controlling interest		3569	3 314
Total equity		34,066	27 818
EQUITY AND TOTAL LIABILITIES		49,446	42,256

Consolidated income statement

in thousands of euros	To note	2Q 2021	2Q 2020	06min 2021	06min 2020
		Unaudited	Unaudited	Unaudited	Unaudited
Revenue from contracts with customers	9	12 960	6 185	23 225	17,731
Cost of goods sold		-5 541	-2 756	-9,564	-7 156
Gross profit		7,419	3429	13 661	10,575

Broadcast costs		-2,094	-1 713	-4 204	-4,447
Administrative expenses		-903	-811	-1 788	-1 933
Other exploitation products		385	70	566	129
Other operating expenses		-151	-144	-294	-341
Operating result		4,656	831	7 941	3 983

Foreign exchange income / (charges)		605	2,174	1,060	-2,556
Other financial income / (expense)		-106	-109	-216	-234
Net financial income		499	2,065	844	-2 790

Profit (loss) of associates using the equity method		5	0	-1	0
Profit before tax		5 160	2,896	8 784	1,193

Income tax expense		-1,028	-586	-2,088	-323

Profit for the period		4 132	2310	6,696	870
Attributable to:
Shareholders of the parent company		3,770	2 151	6,031	745
Non-controlling interest		362	159	665	125

Earnings per share of profit attributable to shareholders of the parent company, both basic and diluted (EUR)	8	0.10	0.06	0.17	0.02

Consolidated statement of comprehensive income

in thousands of euros	To note	2Q 2021	2Q 2020	06min 2021	06min 2020
		Unaudited	Unaudited	Unaudited	Unaudited
Profit for the period		4 132	2310	6,696	870

Other comprehensive income items that will be reclassified to income in subsequent periods:
Exchange differences on the conversion of transactions abroad		40	166	269	-2,059
Total other comprehensive income for the period		40	166	269	-2,059

Total comprehensive income (loss) for the period		4,172	2,476	6 965	-1 189
Attributable to:
Shareholders of the parent company		3 829	2 331	5,993	-1 652
Non-controlling interest		343	145	972	463

Consolidated statement of cash flows

in thousands of euros	06min 2021	06min 2020
	Unaudited	Unaudited
Cash flow from operating activities
Profit for the period	6,696	870
Adjustments for:
Depreciation and amortization of non-current assets	1,592	1 948
Share of profit of associates	1	0
(Gains) / losses on sale of property, plant and equipment	0	3
Net financial income / expense	-596	212
Provision for stocks	4	1
Receipt of government grants	450	0
Movements of provisions and public subsidies	-394	0
Income tax expense	2,088	323
Inventory change	-1,469	1,114
Change in trade and other receivables	-289	219
Change in trade payables and other payables	639	-1 210
Interest paid	-2	0
Income tax paid	-665	-738
Net cash flow from operating activities	8 055	2,742

Cash flow from investing activities
Interest received	9	7
Proceeds from disposal of tangible fixed assets	18	28
Acquisition of tangible fixed assets	-120	-133
Acquisition of intangible assets	-82	-67
Net cash flow from investing activities	-175	-165

Cash flow from financing activities
Acquisition of non-controlling interests	0	-26
Loan proceeds	0	200
Repayment of loans	-800	0
Payment of principal of rental debts	-1 135	-1,006
Interest paid on finance lease	-224	-255
Dividends paid	-717	-474
Net cash flow from financing activities	-2 876	-1 561

Increase in cash and cash equivalents	5,004	1,016
Cash and cash equivalents at the start of the period	8 980	5,152
Effect of exchange rate fluctuations on cash held	38	184
Cash and cash equivalents at the end of the period	14,022	6,352

Jarek Sargava
AS Silvano Fashion Group
Member of the board
Telephone: +372 6845 000
Email: [email protected]

SFG consolidated half-year financial report for the 2nd and 6th quarters of 2021 unaudited

August 6, 2021

Silvano Fashion Group Consolidated Interim Financial Report

Selected financial indicators

The summary of the Group’s selected financial indicators for 6 months 2021 compared to 6 months 2020 and 06/30/2021 compared to 12/31/2020 is as follows:

in thousands of euros	06min 2021	06min 2020	Change
Income	23 225	17,731	31.0%
Gross profit	13 661	10,575	29.2%
Operating result	7 941	3 983	99.4%
EBITDA	9,533	5,931	60.7%
Net income for the period	6,696	870	669.7%
Net income share of shareholders of the Parent Company	6,031	745	709.5%
Earnings per share (EUR)	0.17	0.02	750.0%
Operating cash flow for the period	8 055	2,742	193.8%

in thousands of euros	06/30/2021	31.12.2020	Change
Total assets	49,446	42,256	17.0%
Total current assets	36,381	29,597	22.9%
Total equity attributable to shareholders of the Parent Company	30,497	24,504	24.5%
Cash and cash equivalents	14,022	8 980	56.1%

Margin analysis,%	06min 2021	06min 2020	Change
Gross profit	58.8	59.6	-1.3%
Operating result	34.2	22.5	52.0%
EBITDA	41.0	33.4	22.8%
Net profit	28.8	4.9	487.8%
Net income attributable to shareholders of the Parent Company	26.0	4.2	519.0%

Financial ratios,%	06/30/2021	31.12.2020	Change
ROA	23.7	3.2	640.6%
DEER	40.2	5.6	617.9%
Price / earnings ratio (P / E)	5.5	41.7	-86.8%
Current ratio	4.0	3.4	17.6%
Quick report	1.8	1.3	38.5%

Financial performance

Consolidated operating income for the six months of 2021 amounted to € 7,941 thousand, compared to € 3,983 thousand for the six months of 2020, up 99.4%. The consolidated operating margin stands at 34.2% over 6 months 2021 (22.5% over 6 months 2020). Consolidated EBITDA for the 6 months of 2021 increased by 60.7% and amounted to 9,533 thousand euros, or 41.0% in terms of margin (5,931 thousand euros and 33.4% for the 6 months of 2020).

Financial situation

As of June 30, 2021, consolidated assets amounted to 49,446 thousand euros, an increase of 17.0% compared to the situation as of December 31, 2020.

Trade and other receivables increased by 273 thousand EUR compared to 31 December 2020 and amount to 2,361 thousand EUR as of 30 June 2021. The inventory balance increased by 1,469 thousand EUR and amounts to EUR 19,996 thousand as of June 30, 2021.

Equity attributable to shareholders of the parent company increased by € 5,993 thousand and amounted to € 30,497 thousand as of June 30, 2021. Current liabilities increased by € 255 thousand over the 6 month 2021.

Investments

During the 6 months of 2021, the Group’s investments in tangible fixed assets amounted to 120,000 EUR, compared to 133,000 EUR for the same period of the previous year. Investments were made primarily in the opening and renovation of clean stores, as well as in equipment and facilities to maintain efficient production for future periods.

Staff

Consolidated statement of financial position

in thousands of euros	To note	06/30/2021	31.12.2020
		Unaudited	Checked
ASSETS
Current assets
Cash and cash equivalents	2	14,022	8 980
Outstanding loans granted		2	2
Customers and other debtors	3	2,361	2,088
Inventories	4	19,996	18,527
Total current assets		36,381	29,597

Non-current assets
Long-term receivables		268	249
Investments in associated companies		59	57
Investments in other actions		250	238
Deferred tax asset		1,091	1,032
Intangible assets		462	374
Investment property		1,053	1,018
Tangible fixed assets	5	9 882	9,691
Total non-current assets		13,065	12 659
TOTAL ASSETS		49,446	42,256

LIABILITIES AND EQUITY
Current liabilities
Short-term loans		0	400
Short-term rental debts		1,283	2 121
Suppliers and other creditors	6	5 815	5,583
Government grants		56	0
Tax debts		1,880	675
Total current liabilities		9,034	8,779

Non-current liabilities
Deferred tax liability		584	500
Long term loans		0	400
Long-term rental obligations		5,707	4,707
Long-term arrangements		55	52
Total non-current liabilities		6,346	5 659
Total responsibilities		15,380	14,438

Equity
Share the capital	7	3,600	3,600
Sharing bonus		4,967	4,967
Statutory reserve capital		1,306	1,306
Revaluation reserve		0	355
Unrealized exchange differences		-18,547	-18,864
Retained earnings		39,171	33 140
Total equity attributable to shareholders of the Parent Company		30,497	24,504
Non-controlling interest		3569	3 314
Total equity		34,066	27 818
EQUITY AND TOTAL LIABILITIES		49,446	42,256

Consolidated income statement

in thousands of euros	To note	2Q 2021	2Q 2020	06min 2021	06min 2020
		Unaudited	Unaudited	Unaudited	Unaudited
Revenue from contracts with customers	9	12,960	6 185	23 225	17,731
Cost of goods sold		-5 541	-2 756	-9,564	-7 156
Gross profit		7,419	3429	13 661	10,575

Broadcast costs		-2,094	-1 713	-4 204	-4,447
Administrative expenses		-903	-811	-1 788	-1 933
Other exploitation products		385	70	566	129
Other operating expenses		-151	-144	-294	-341
Operating result		4,656	831	7 941	3 983

Foreign exchange income / (charges)		605	2,174	1,060	-2,556
Other financial income / (expense)		-106	-109	-216	-234
Net financial income		499	2,065	844	-2 790

Profit (loss) of associates using the equity method		5	0	-1	0
Profit before tax		5 160	2,896	8 784	1,193

Income tax expense		-1,028	-586	-2,088	-323

Profit for the period		4 132	2310	6,696	870
Attributable to:
Shareholders of the parent company		3,770	2 151	6,031	745
Non-controlling interest		362	159	665	125

Earnings per share of profit attributable to shareholders of the parent company, both basic and diluted (EUR)	8	0.10	0.06	0.17	0.02

Consolidated statement of comprehensive income

in thousands of euros	To note	2Q 2021	2Q 2020	06min 2021	06min 2020
		Unaudited	Unaudited	Unaudited	Unaudited
Profit for the period		4 132	2310	6,696	870

Other comprehensive income items that will be reclassified to income in subsequent periods:
Exchange differences on the conversion of transactions abroad		40	166	269	-2,059
Total other comprehensive income for the period		40	166	269	-2,059

Total comprehensive income (loss) for the period		4,172	2,476	6 965	-1 189
Attributable to:
Shareholders of the parent company		3 829	2 331	5,993	-1 652
Non-controlling interest		343	145	972	463

Consolidated statement of cash flows

in thousands of euros	06min 2021	06min 2020
	Unaudited	Unaudited
Cash flow from operating activities
Profit for the period	6,696	870
Adjustments for:
Depreciation and amortization of non-current assets	1,592	1 948
Share of profit of associates	1	0
(Gains) / losses on sale of property, plant and equipment	0	3
Net financial income / expense	-596	212
Provision for stocks	4	1
Receipt of government grants	450	0
Movements of provisions and public subsidies	-394	0
Income tax expense	2,088	323
Inventory change	-1,469	1,114
Change in trade and other receivables	-289	219
Change in trade payables and other payables	639	-1 210
Interest paid	-2	0
Income tax paid	-665	-738
Net cash flow from operating activities	8 055	2,742

Cash flow from investing activities
Interest received	9	7
Proceeds from disposal of tangible fixed assets	18	28
Acquisition of tangible fixed assets	-120	-133
Acquisition of intangible assets	-82	-67
Net cash flow from investing activities	-175	-165

Cash flow from financing activities
Acquisition of non-controlling interests	0	-26
Loan proceeds	0	200
Repayment of loans	-800	0
Payment of principal of rental debts	-1 135	-1,006
Interest paid on finance lease	-224	-255
Dividends paid	-717	-474
Net cash flow from financing activities	-2 876	-1 561

Increase in cash and cash equivalents	5,004	1,016
Cash and cash equivalents at the start of the period	8 980	5,152
Effect of exchange rate fluctuations on cash held	38	184
Cash and cash equivalents at the end of the period	14,022	6,352

Jarek Sargava
AS Silvano Fashion Group
Member of the board
Telephone: +372 6845 000
Email: [email protected]

SFG half-year consolidated financial report for the 2nd and 6th quarters of 2021 unaudited

August 4, 2021

Thiruvananthapuram Corporation Pass Administration Report, Financial Statements

A Thiruvananthapuram City Society Council meeting on Wednesday adopted the annual administrative report for 2019-2020 and the annual financial statements for 2020-2021, after more than two hours of intense debate.

Mayor Arya Rajendran said changes, if necessary, would be made to the financial statements, based on certain discrepancies, as some of the opposition advisers pointed out.

The reports were presented to council for discussion in accordance with requests raised by opposition councilors at a previous council meeting. Bharatiya Janata Party (BJP) advisers Anilkumar and Karamana Ajith alleged that there were discrepancies in the number of vehicles owned by the company, according to the administrative report and in responses to questions from RTI.

Some vehicles were reported as missing in the administrative report. The advisers demanded that the Corporation file a complaint with the police and take action against the officials responsible for dereliction of duty. Standing committee chairman Dr Anil said he revealed the issue of missing vehicles at a previous council meeting and therefore BJP advisers should refrain from presenting it as their conclusion.

Ms Rajendran said a search committee had been formed to determine which vehicles were actually missing. Some of the vehicles had been abandoned in various places, as they were previously used for decentralized waste collection, which was no longer the case. The possibility of reusing some of these vehicles would be explored. A complaint would only be lodged with the police for vehicles that have actually disappeared.

Housing projects

BJP adviser MR Gopan also questioned the figures regarding housing projects in the administrative report. He said hardly any houses had been completed as part of the LIFE project in the company. The chairman of the social protection committee, S. Salim, denied these allegations, saying that the state had also increased funding for PMAY housing projects, in line with LIFE projects, and therefore gave more funds to beneficiaries for construction. more homes than all other states.

Tax liability

During the discussion of the annual financial statements, BJP adviser P. Ashokkumar alleged that the report was riddled with errors. There was a significant tax debt of ₹ 200 crore in the report. Details of people or institutions that owed taxes were to be made public, he said.

The ₹ 55 crore deputy mayor was part of the unpaid tax amount that had been passed on over the years. However, the remainder of the amount included expected government funds for this fiscal year.

August 4, 2021

Albioma: Availability of the Half-Year Financial Report

Press release

Paris La Défense, August 4, 2021

Availability of the half-year financial report

First half of fiscal year 2021

Albioma announces that, today, the French version of its Half-Year Financial Report for the first half of fiscal year 2021 (6-month period from January 1 to June 30, 2021) has been made available to the public and filed with the Financial Markets Authority (Financial Markets Authority). The English version of the half-year financial report will be available shortly.

The Half-Year Financial Report can be viewed on the Company’s website, www.albioma.com.

On the agenda: sales for the third quarter of fiscal year 2021, October 20, 2021 (post market).

About Albioma	Contacts
An independent producer of renewable energies, Albioma is committed to the energy transition thanks to biomass and photovoltaics. Albioma is present in French overseas territories, mainland France, Mauritius and Brazil. For 25 years, it has been developing a unique partnership with the sugar industry to produce renewable energy from bagasse, the fibrous residue from sugar cane. Albioma is the leading producer of photovoltaic energy in the French Overseas Territories, where the company builds and operates innovative projects with storage, Albioma has strengthened its position in mainland France. Recently, the Group announced the acquisition of a geothermal power plant in Turkey.	Investor Julien gauthier +33 (0) 1 47 76 67 00 Media Charlotte neuvy +33 (0) 1 47 76 66 65 [email protected]

Albioma is listed on Euronext Paris compartment A, is eligible for the deferred settlement service (SRD), the PEA and the PEA-PME and is part of the SBF 120 and the CAC Mid 60. The Group is also part of the Gaïa-Index, an index of socially responsible average values.	www.albioma.com

Attachment

August 2, 2021

Global Financial Statement Fraud Market to Record Explosive Growth in 2021

Financial Statement Fraudulent Marketing report sheds light on each region, the market size in terms of (USD Million) for each individual segment and their sub-segment for the period, taking into account macro and micro situation factors. The document gives a brief introduction to the research report outlook, table of contents, list of tables and figures, outlook for major market players and including key regions. A detailed summary of Financial Statement Fraud Market includes a prominent market which includes several key market leaders in the report. The report requires in-depth analysis of the product manufactured by the vendors in combination with the range of applications of the product.

Financial statement fraud market covering key business segments and geographies at scale to get deeply analyzed market data. This Financial Statement Fraud report includes the most detailed market segmentation, systematic analysis of major market players, trends in consumer and supply chain dynamics, and insights into emerging geographic markets. Systematic investment analysis is also highlighted in this report on financial statement fraud which predicts imminent opportunities for market players. This market report contains the company profiles, product specifications, capacity, production value and market shares of each company for the forecast period. All statistical and numerical data included in the report are characterized using graphs and tables, making it easy to understand facts and figures. Some of the key and emerging players that are part of the coverage and have been profiled are BioCatch, Digital Resolve, Experian plc, Gemalto NV, Kount Inc., Signifyd,

Get Exclusive Sample Financial Statement Fraud Market Report Spread Over 350 Pages, Profile Of Major Market Players Are Available At https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-financial-statement-fraud-market

The Financial Statement Fraud Market is expected to experience market growth at a rate of 18.30% during the forecast period of 2020 to 2027. The Data Bridge Market Research Report on the Financial Statement Fraud Market provides analysis and information on the various factors that are expected to prevail throughout the forecast period while providing their impacts on the growth of the market.

Global Financial Statement Fraud Market Dynamics:

Global Financial Statement Fraud Market Scope and Market Size

The financial statement fraud market is segmented on the basis of form, warning sign, method of detection, and application. Growth among segments helps you analyze growth niches and strategies to approach the market and determine your main areas of application and the difference in your target markets.

The form-based financial statement fraud market has been segmented by overstating income, inflating equity in an asset, masking obligations / liabilities, and incorrectly disclosing related party transactions.
Based on a warning sign, the financial statement fraud market has been segmented into accounting anomalies, steady sales growth, depreciation methods, weak internal corporate governance, disproportionate frequency of complex third-party transactions, missing documents and encourages fraud.
Based on the detection method, the financial statement fraud market has been segmented into horizontal financial statement analysis and vertical financial statement analysis.
Based on the application, the financial statement fraud market has been segmented into defense, government, banks and financial institutions, and others.

Important Features of the Global Financial Statement Fraud Market Report:

1) What all companies are currently described in the report?

List of players who are currently featured in the report- ACTICO GmbH, CipherCloud, GlobalVision Systems, Inc., Oracle, among others

** List of companies mentioned may vary in final report subject to name change / merger etc.

2) What did all the regional segmentation cover? Can a country of specific interest be added?

Currently, the research report pays special attention and focuses on the following regions:

North America, Europe, Asia-Pacific etc.

** A country of specific interest may be included at no additional cost. For the inclusion of a more regional segment, the quote may vary.

3) Is the inclusion of additional market segmentation / allocation possible?

Yes, inclusion of further segmentation / market breakdown is possible subject to data availability and survey difficulty. However, a detailed requirement should be shared with our research before giving the final confirmation to the client.

** Depending on needs, delivery time and quote will vary.

Global Financial Statement Fraud Market Segmentation:

By form

Overestimate income, inflate the net worth of an asset,
Hide obligations / responsibilities,
Incorrect disclosure of related party transactions

Warning sign

Accounting anomalies,
Constant sales growth,
Depreciation methods,
Weak internal corporate governance,
Inordinate frequency of complex third-party transactions,
Missing documents,
Encourages fraud

Detection method

Horizontal analysis of financial statements,
Vertical analysis of financial statements

Application

Defense,
Government,
Banks and financial institutions, Others

New business strategies, challenges and policies are mentioned in the table of contents, Request TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-financial-statement-fraud-market

Strategic Points Covered In The Table Of Contents Of Global Financial Statement Fraud Market:

Chapter 1: Introduction, Market Driving Product Study Objective and Research Scope Financial Statement Fraud Market

Chapter 2: Exclusive summary – the basic information of the financial statement fraud market.

Chapter 3: Displaying Market Dynamics – Drivers, Trends and Challenges of Floating Silicon

Chapter 4: Introducing Porters Five Forces Financial Statement Fraud Market Factor Analysis, Supply / Value Chain, PESTEL Analysis, Market Entropy, Patent / Trademark Analysis.

Chapter 5: View by type, end user and region 2013-2018

Chapter 6: Evaluate the major manufacturers in the financial statement fraud market which consists of its competitive landscape, peer group analysis, BCG matrix and company profile

Chapter 7: To assess the market by segments, by country and by manufacturer with revenue and sales share by key countries in these various regions.

Chapter 8 & 9: Display of appendix, methodology and data source

Regional analysis of major producers and consumers, focusing on product capacity, production, value, consumption, market share and growth opportunities in the key regions mentioned below:

North America – United States, Canada, Mexico

Europe : UK, France, Italy, Germany, Russia, Spain, etc.

Asia Pacific – China, Japan, India, Southeast Asia etc.

South America – Brazil, Argentina, etc.

Middle East and Africa – Saudi Arabia, African countries, etc.

Key strategic points of the report on financial statement fraud:

Production analysis – The production of the patient treatment equipment is analyzed based on different regions, types and applications. Here, the price analysis of various key players in the Financial Statement Fraud market is also covered.

Sales and Revenue Analysis – Sales and revenue are studied for different regions of the Financial Statement Fraud market. Another major aspect, the price, which plays an important role in generating income, is also assessed in this section for the different regions.

Supply and consumption – In continuation of sales, this section studies the supply and consumption of the Financial Statements Fraud Market. This section also highlights the gap between supply and consumption. Import and export figures are also given in this section.

Competitors – In this section, various leading Financial Statement Fraud industry players are studied based on their company profile, product portfolio, capacity, price, cost, and revenue.

Analysis tools – The Financial Statement Fraud Market report comprises accurately researched and assessed information on key players and their market scope with the help of several analytical tools including SWOT analysis, five forces analysis Porter, ROI analysis and feasibility study. These tools have been used to effectively study the growth of key industry participants.

The 360 degree overview of financial statement fraud based on a global and regional level. Market share, value, volume and production capacity are analyzed at global, regional and country level. And a comprehensive and useful guide for new market aspirants
Facilitates decision making based on outstanding insight and valuation, as well as available market drivers and limitations.

For more details on this report: https://www.databridgemarketresearch.com/reports/global-financial-statement-fraud-market

Queries related to the financial statement fraud market:

Which application segments will perform best and be successful around the world over the forecast years?
What are the key factors driving the growth of the market?
Who are the main suppliers in this industry?
What are the impressive industries where the best players want their own expansion in the future?
What are the dynamics of the market?
What are the limits that ruin the rate of development?
What is the circumstance targeted to advance development?
What are the opportunities and threats that performers face in the global market?
What are the development rates of this industry?

About the Data Bridges Market Research:

An absolute way to predict what the future holds is to understand the trend today!
Data Bridge has established itself as an unconventional, neoteric market research and consulting company with an unprecedented level of resilience and integrated approaches. We are committed to finding the best market opportunities and promoting effective information for your business to thrive in the market.

Contact:

United States: +1 888 387 2818

UK: +44 208 089 1725

Hong-Kong: +852 8192 7475

[email protected]

July 31, 2021

Analysts made a financial statement on the annual report of Axos Financial, Inc. (NYSE: AX)

Last week saw the latest release of annual results for Axos Financial, Inc. (NYSE: AX), an important step in the company’s journey to building a stronger business. Revenue was 4.0% lower than expected at $ 620 million. Statutory earnings per share were relatively better, with earnings per share of $ 3.56 roughly matching analyst estimates. Following the result, analysts updated their earnings model, and it would be good to know if they think there has been a significant change in the outlook for the company, or if it is like habit. So we’ve put together the latest post-earnings forecast to see what the estimates suggest for next year.

Check out our latest analysis for Axos Financial

NYSE: AX Profit and Revenue Growth as of July 31, 2021

After the latest results, the five analysts covering Axos Financial now forecast revenue of US $ 695.8 million in 2022. If achieved, this will reflect a significant 12% improvement in sales over the last 12 month. Statutory earnings per share are expected to decline 2.5% to $ 3.55 over the same period. Yet before the latest results, analysts were forecasting revenues of US $ 702.9 million and earnings per share (EPS) of US $ 3.57 in 2022. So it’s pretty clear that although analysts have put to update their estimates, there has been no major change in the company’s expectations as a result of the latest results.

Analysts reconfirmed their price target of US $ 55.50, demonstrating that the business is performing well and in line with expectations. Sticking to a single price target can be unwise, however, as the consensus target is actually the average of analysts’ price targets. As a result, some investors like to look at the range of estimates to see if there are any differing opinions on the valuation of the company. Currently, the most bullish analyst values Axos Financial at US $ 60.00 per share, while the most bearish the price at US $ 52.00. Still, with such a narrow range of estimates, it suggests that analysts have a pretty good idea of what they think the company is worth.

Of course, another way to look at these forecasts is to put them in context to the industry itself. We can infer from the latest estimates that the forecast is for Axos Financial’s historical trends to continue, as the 12% annualized revenue growth through the end of 2022 is roughly in line with the 13% annual revenue growth. over the past five years. Compare that with the industry as a whole (as a whole), which analysts estimate will see its revenue fall by 3.1% per year. Thus, not only is Axos Financial expected to maintain revenue growth despite the more general slowdown, but it is also expected to grow faster than the industry as a whole.

The bottom line

The most obvious conclusion is that there hasn’t been a major change in the outlook for the company lately, with analysts keeping their earnings forecasts stable, in line with previous estimates. On the bright side, they haven’t made any changes to their revenue estimates – and they expect sales to be better than the industry as a whole. The consensus price target remained at US $ 55.50 as the latest estimates were not sufficient to impact their price targets.

With this in mind, we still believe that the long-term trajectory of the company is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Axos Financial through 2024, and you can view them for free on our platform here.

You should always take note of the risks, for example – Axos Financial has 1 warning sign we think you should be aware.

Promoted
When trading Axos Financial or any other investment, use the platform considered by many to be the gateway for professionals to the global market, Interactive Brokers. You get the cheapest * trading on stocks, options, futures, forex, bonds and funds from around the world from a single integrated account.

This Simply Wall St article is general in nature. It does not constitute a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Our aim is to bring you long-term, targeted analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price sensitive companies or qualitative documents. Simply Wall St has no position in the mentioned stocks.
^*Interactive Brokers Ranked Least Expensive Broker By StockBrokers.com Online Annual Review 2020

Do you have any feedback on this item? Are you worried about the content? Enter into a contract with us directly. You can also send an email to the editorial team (at) simplywallst.com.

July 30, 2021

Publication of the 2021 interim financial report

Publication of the 2021 interim financial report

Charenton-le-Pont, France (July 30, 2021 – 6.30amafternoon) – The Board of Directors of EssilorLuxottica met yesterday to approve the condensed half-year consolidated financial statements for the six-month period ended June 30, 2021.

EssilorLuxottica’s 2021 interim financial report was published today.

The half-year financial report includes, in addition to the press release announcing the first half-year results, the condensed half-year consolidated financial statements, the half-year management report, the declaration by those responsible for the half-year financial report and the auditors’ review report.

The Interim Financial Report can be downloaded from the Company’s website, https://www.essilorluxottica.com/, section “Investors / Publications and Downloads”, or by clicking on:
https://www.essilorluxottica.com/sites/default/files/documents/2021-07/2021.06_EN_INTERIM%20Financial%20Report_Final.pdf

EssilorLuxottica is a world leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, its mission is to help people around the world see more, be more, and live life to the fullest by meeting their evolving vision needs and personal style aspirations. The company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craft of iconic eyewear, to set new industry standards for skin care. the view and experience of the consumer around them. Influential eyewear brands such as Ray-Ban and Oakley, lens technology brands such as Varilux and Transitions, and world-class distribution brands such as Sunglass Hut and LensCrafters as well as – since July 1, 2021 via stake 76.72% – the GrandVision network is part of the EssilorLuxottica network. family. In 2020, EssilorLuxottica had more than 140,000 employees and a consolidated turnover of 14.4 billion euros. EssilorLuxottica shares are listed on the Euronext Paris market and are part of the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESLX.PA; Bloomberg: EL: FP.

CONTACTS

Head of Investor Relations Head of corporate communications
Giorgio Iannella Marco Catalani
e-mail: [email protected] e-mail: [email protected]

Attachment

John V. Yarnell Financial liabilities 0 Comments

July 27, 2021

MorphoSys AG to Update Financial Forecast for 2021 and Reduce Financial Liabilities

Based on the unaudited preliminary consolidated results for the first half of 2021, MorphoSys now expects Group sales of between 155 and 180 million euros (previously: 150 to 200 million euros, communicated on 15 March 2021 and reiterated on May 5, 2021). The updated revenue forecast primarily reflects the updated Monjuvi (R) product sales expectations. PLANEGG / MUNICH, GERMANY / ACCESSWIRE / July 26, 2021 / MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announces an update to its financial guidance for 2021 following the preliminary completion of the latest assessment of the financial performance of the 2021 semester of MorphoSys.

Following the update of sales forecasts for Monjuvi products, the balance sheet position “Financial liabilities of collaborations, net of the current part” is reduced from 547.6 million euros (balance at March 31, 2021) to 445.9 million euros (balance as of 30, 2021). The balance of “Financial liabilities of collaborations, net of the current part” reflects an accounting view of the expected profits from the net sales of Monjuvi products in the United States within the framework of the DLBCL r / r due to our partner Incyte. The reduction in Collaborations’ Financial Liabilities has no impact on cash flow.

MorphoSys now expects the Group’s operating expenses, which include R&D and sales, as well as general and administrative expenses, to be between 435 and 465 million euros (previously: 355 to 385 million euros). ‘euros). R&D expenses should now represent 52 to 57% of the Group’s operating expenses (previously 45 to 50%), excluding one-off transaction costs. The updated forecast of the Group’s operating expenses mainly reflects the acquisition of Constellation Pharmaceuticals (Constellation), which was finalized on July 15, 2021. The revised range of the Group also includes non-recurring transaction costs of 36 million euros , related to agreements with Constellation and Royalty Pharmacy.

The story continues

Full results will be released as scheduled on July 28, 2021.

***

END OF AD HOC BROADCAST

About MorphoSysMorphoSys (FSE & NASDAQ: MOR) is a biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for people with cancer and autoimmune diseases. Based on its cutting-edge expertise in antibody and protein technologies, MorphoSys is developing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical needs. In 2017, Tremfya (R) (guselkumab) – developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis – became the first drug based on MorphoSys antibody technology to receive regulatory approval. In July 2020, the US Food and Drug Administration granted fast-track approval of the company’s proprietary product Monjuvi (R) (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma. Based near Munich, Germany, the MorphoSys group, including 100% US subsidiaries MorphoSys US Inc. and Constellation Pharmaceuticals, Inc., has more than 750 employees. For more information, visit www.morphosys.com.

Information and explanation from the issuer to this news:

Monjuvi (R) is a registered trademark of MorphoSys AG. Tremfya (R) is a registered trademark of Janssen Biotech, Inc.

Forward-looking statements This communication contains certain forward-looking statements concerning the MorphoSys group of companies. The forward-looking statements contained in this document represent the judgment of MorphoSys as of the date of this press release and involve known and unknown risks and uncertainties, which could lead to the actual results, financial situation and liquidity, performance or achievements of MorphoSys. , or industry results, be materially different from historical or future results, financial conditions and liquidity, performance or achievements expressed or implied by such forward-looking statements. In addition, even if the results, performance, financial position and liquidity of MorphoSys, as well as the development of the industry in which it operates are consistent with these forward-looking statements, they may not be predictive of the results or developments. for future periods. Factors that may cause differences include the fact that MorphoSys’ expectations may be incorrect, inherent uncertainties associated with competitive developments, clinical trials and product development activities and regulatory approval requirements, dependence on MorphoSys collaborations with third parties, estimating the commercial potential of its development programs and other risks indicated in the risk factors included in MorphoSys’ annual report on Form 20-F and other documents filed with the Securities and Exchange Commission the United States. In view of these uncertainties, readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date of publication of this document. MorphoSys expressly disclaims any obligation to update any such forward-looking statements in this document to reflect any change in its expectations in this regard or any change in the events, conditions or circumstances on which such statement is based or which may affect the likelihood that results will differ from those set forth in forward-looking statements, unless specifically required by law or regulation.

For more information please contact:

Dr. Julia Neugebauer Senior Director of Investor Relations Tel: +49 (0) 89/899 27 179 [email protected]

Myles Clouston Senior Director of Investor Relations Tel: +1 [email protected]

SOURCE: MorphoSys AG

See the source version on accesswire.com: https://www.accesswire.com/657002/MorphoSys-AG-to-Update-Financial-Guidance-for-2021-and-Reduce-Financial-Liabilities

News Business Highlights

MorphoSys AG to Update Financial Forecast for 2021 and Reduce Financial Liabilities
Check out all the news and articles for business news updates.

Disclaimer: If you need to update / change this news or article, please visit our help center.